Overview
Submission Instructions
Recent Publications
Frequently Asked Questions
Research Topics
Looking to publish in Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite Now
OR
Oncology Research is an open access monthly journal that publishes high-quality, innovative research across the full range of basic, translational, and clinical cancer research, with particular interest in cancer therapeutics and work that advances understanding, prevention, diagnosis, and treatment of cancer.
Looking to publish in Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite Now
Subject
Oncology
Impact Factor
4.1
Quartile
Q2
Open Access Type
Open
ISSN
0965-0407
eISSN
1555-3906
Invitation Only
No
Cost Range
2200 USD APC per accepted paper.
Submission Instructions
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics accepts the following article types. Click on an article type to view submission instructions.
Research Articles
Cover Letter
A cover letter is required for Research Articles. The cover letter must state originality, confirm all authors approved the final manuscript and accept responsibility, disclose any ethical, copyright, or disclosure issues, declare conflicts of interest or none, and disclose any non-linguistic AI or AI-assisted tool use.
Abstract
An abstract is required for Research Articles. The abstract should typically be 200 to 400 words in length. The abstract must be structured. The abstract must use labeled sections such as Introduction or Objectives or Background, Methods, Results, and Conclusion.
Manuscript
Research Articles must include Title, Keywords, Authors and Affiliations, Abstract, Introduction, Material and Methods, Results, Discussion, and Conclusion, with a structured main text format such as Introduction, Results, Discussion, Methods, and Conclusions. Research Articles must include keywords, and an Author Contributions statement is mandatory except for single-author papers, while AI tool use must be disclosed in the Materials and Methods section and acknowledged in the Acknowledgments section when used.
References
References must follow Vancouver style. References must be cited sequentially in the text using square-bracketed numbers and listed at the end, including the DOI where available and listing the first six authors before using et al.
Figures & Tables
Figures should be inserted into the main text immediately after first citation, and all figures and tables should be inserted in the text of the manuscript. Figures and tables must be numbered consecutively in Arabic numerals and cited in sequential order in the main text, with figures carrying captions underneath and tables provided in editable MS Word format rather than as images.
Review Articles
Cover Letter
A cover letter is required. Cover letter must state that the manuscript is original, all authors approved the final manuscript and submission, disclose any copyright or disclosure issues and conflicts of interest, and declare any AI or AI-assisted tool use except linguistic editing alone.
Abstract
An abstract is required. Abstract should be 150 to 300 words in length. Abstract should be unstructured.
Manuscript
Review Articles may use a flexible main text structure, while systematic reviews and meta-analyses should use the same structure as Research Articles. Manuscript must include 3 to 10 keywords and end sections for Acknowledgment, Funding Statement, Author Contributions, Conflicts of Interest, and an Acknowledgments disclosure naming any generative AI tool and version used.
References
References must use Vancouver style. References must be cited sequentially in square brackets, listed individually at the end, include the DOI where available, and list the first 6 authors before using et al.
Figures & Tables
Figures and tables should be inserted in the text of the manuscript, with figures placed immediately after the paragraph where they are first cited. Figures and tables must be numbered consecutively in Arabic numerals and cited first in sequential order in the main text.
Case Reports
Cover Letter
A cover letter is required. Cover letter must state that the manuscript is original, not previously published or under consideration elsewhere, approved by all authors, and include any conflict of interest and any use of AI or AI-assisted tools in manuscript preparation except solely for linguistic editing.
Abstract
Abstract must be unstructured and written as a continuous paragraph without reference citations.
Manuscript
Manuscript should include Introduction, Case Presentation, Discussion, and Conclusion sections. Manuscript must include 3 to 10 keywords, required end sections such as Acknowledgment, Funding Statement, Author Contributions, and Conflicts of Interest, and must declare consent for publication in the manuscript when potentially identifiable case details or images are included.
References
References must follow Vancouver style. References must be cited sequentially in square brackets and listed at the end of the manuscript with the first 6 authors named before using et al.
Figures & Tables
Figures and tables should be inserted in the text of the manuscript, with figures placed immediately after the paragraph where they are first cited. Figures and tables must be numbered consecutively in Arabic numerals and cited in sequential order in the main text.
Analysis
Cover Letter
A cover letter is required. Cover letter must state that the manuscript is original, not previously published or under consideration elsewhere, all authors approved the final manuscript and accept responsibility for it, any ethical or copyright issues are disclosed, conflicts of interest are declared, and any AI-assisted manuscript preparation beyond linguistic editing is disclosed.
Abstract
An abstract is required. Abstract must be structured for this article type despite the general requirement that abstracts run continuously. Abstract must include labeled sections such as Introduction or Objectives or Background, Methods, Results, and Conclusion.
Manuscript
Main text must be approximately 3,000 words excluding the Abstract, Online Methods, References, and Figure legends. Manuscript should use the main headings Introduction, Material and Methods, Results or Systematic Description, Discussion, Conclusion, and Acknowledgements if necessary, with Results and Discussion presented separately. Manuscript must include 3 to 10 keywords and end sections for Acknowledgment, Funding Statement, Author Contributions, Availability of Data and Materials, Ethics Approval, and Conflicts of Interest, and any use of generative AI beyond linguistic editing must be disclosed in the Materials and Methods section and acknowledged with the tool name and version in Acknowledgments.
References
References are limited to 50. References must follow Vancouver style. References must be cited sequentially in square brackets, listed individually at the end, include DOI where available, and list all authors if there are six or fewer or the first six followed by et al. if there are more than six.
Figures & Tables
Figures and tables should be inserted in the text of the manuscript, with figures placed immediately after first citation in Word manuscripts. Figures and tables must be numbered consecutively in Arabic numerals and cited in sequential order, each figure must have a caption or legend, tables must be editable rather than images, and all panels of a multi-panel figure must be assembled into a single file.
Letters
Cover Letter
A cover letter is required. Cover letter must state that the manuscript is original, not previously published or under consideration elsewhere, approved by all authors, and disclose any copyright or conflict-of-interest issues including AI tool use beyond linguistic editing.
Abstract
Abstract must be unstructured and written as a continuous paragraph without reference citations.
Manuscript
Manuscript should include front matter with Title, Author list, Affiliations, Abstract, and Keywords and use main headings of Introduction, Material and Methods, Results or Systematic Description, and Discussion, with Results and Discussion kept separate. Manuscript must include 3 to 10 keywords and end sections for Acknowledgment, Funding Statement, Author Contributions, and Conflicts of Interest, and any use of generative AI beyond linguistic editing must also be disclosed in the Materials and Methods and Acknowledgments sections.
References
References must follow Vancouver style. References must be cited sequentially in the text using square-bracketed numbers, listed individually at the end, include DOI when available, and list the first six authors before using et al.
Figures & Tables
Figures and tables should be inserted in the manuscript text, with figures placed immediately after first citation in Word manuscripts. Figures and tables must be numbered consecutively in the order first cited, and each figure must include a caption or legend placed underneath.
Recent Publications
ScRNA-seq reveals the correlation between M2 phenotype of tumor-associated macrophages and lymph node metastasis of breast cancer
JUN SHEN, HONGFANG MA, YONGXIA CHEN, JIANGUO SHEN
10.32604/or.2023.029638
View Publication
Polo-like kinase 1 suppresses lung adenocarcinoma immunity through necroptosis
PENGCHENG ZHANG, XINGLONG ZHANG, YONGFU ZHU, YIYI CUI, JING XU, WEIPING ZHANG
10.32604/or.2023.030933
View Publication
Identification of a dihydroorotate dehydrogenase inhibitor that inhibits cancer cell growth by proteomic profiling
MAKOTO KAWATANI, HARUMI AONO, SAYOKO HIRANUMA, TAKESHI SHIMIZU, MAKOTO MUROI, TOSHIHIKO NOGAWA, TOMOKAZU OHISHI, SHUN-ICHI OHBA, MANABU KAWADA, KANAMI YAMAZAKI, SHINGO DAN, NAOSHI DOHMAE, HIROYUKI OSADA
10.32604/or.2023.030241
View Publication
The DMRTA1-SOX2 positive feedback loop promotes progression and chemotherapy resistance of esophageal squamous cell carcinoma
RUI ZHANG, PENG ZHOU, XIA OU, PEIZHU ZHAO, XIJING GUO, MIAN XI, CHEN QING
10.32604/or.2023.030184
View Publication
Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer
SUNG HEE LIM, HEE JIN CHO, KYOUNG-MEE KIM, HO YEONG LIM, WON KI KANG, JEEYUN LEE, YOUNG SUK PARK, HEE CHEOL KIM, SEUNG TAE KIM
10.32604/or.2023.030374
View Publication
Frequently asked questions
How long does it take to publish?
Submission to first post-review decision averages 33 days (2025). Submission to acceptance averages 95 days (2025).
Reformat to Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics using Livewrite PremiumIs a cover letter required?
A cover letter is required with submission. It must state that the manuscript is original, has not been published or submitted elsewhere, confirm all authors approved the submission and accept responsibility for the manuscript, and disclose any ethical, copyright, or conflict-of-interest issues.
Reformat to Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics using Livewrite PremiumWhat are the publication costs?
2200 USD APC per accepted paper after peer review. No surcharges are charged based on article length, figures, or supplementary data.
Reformat to Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics using Livewrite PremiumResearch Topics
Cancer-related molecular mechanisms research
MicroRNA in disease regulation
Circular RNAs in diseases
RNA modifications and cancer
Ferroptosis and cancer prognosis
Cancer, Hypoxia, and Metabolism
RNA Research and Splicing
Cancer Cells and Metastasis
Cancer-related gene regulation
Cancer Immunotherapy and Biomarkers
Cancer-related Molecular Pathways
Cancer Mechanisms and Therapy
Epigenetics and DNA Methylation
Cell death mechanisms and regulation
Lung Cancer Treatments and Mutations
Wnt/β-catenin signaling in development and cancer
Immune cells in cancer
PI3K/AKT/mTOR signaling in cancer
Ubiquitin and proteasome pathways
Cancer therapeutics and mechanisms
Immunotherapy and Immune Responses
Cancer, Lipids, and Metabolism
Colorectal Cancer Treatments and Studies
Cancer Research and Treatments
Peptidase Inhibition and Analysis
Related Journals
CO
Cellular Oncology
Springer Nature
CC
Clinical Cancer Research
American Association for Cancer Research
IA
Infectious Agents and Cancer
BioMed Central
TO
Translational Oncology
Elsevier BV
JO
Journal of Hematology & Oncology
BioMed Central
CJ
Chinese Journal of Cancer Research
AME PUBLISHING COMPANY